Public deliberation to assess patient views on biosimilar medication switching for the treatment of inflammatory bowel disease

• Main Authors: Kerry A. Ryan (Author), Shirley Cohen-Mekelburg (Author), Jessica A. Baker (Author), Eileen M. Weinheimer-Haus (Author), Chris Krenz (Author), Jason K. Hou (Author), Raymond De Vries (Author), Akbar K. Waljee (Author)
• Format: Book
• Published: BMC, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Biosimilars are highly similar, but not identical, versions of originator biologic medications. Switching patients to biosimilars presents an opportunity to mitigate rising drug costs and expand patient access to important biologic therapies. However, decreased patient acceptance...